Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other Non-Current Liabilities: 2024

Historic Other Non-Current Liabilities for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $1.8 million.

  • Kura Oncology's Other Non-Current Liabilities rose 102.65% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 102.65%. This contributed to the annual value of $1.8 million for FY2024, which is N/A change from last year.
  • Per Kura Oncology's latest filing, its Other Non-Current Liabilities stood at $1.8 million for FY2024.
  • Kura Oncology's Other Non-Current Liabilities' 5-year high stood at $1.8 million during FY2024, with a 5-year trough of $1.8 million in FY2024.
  • Its 1-year average for Other Non-Current Liabilities is $1.8 million, with a median of $1.8 million in 2024.